Trexquant Investment’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,023
Closed -$1.58M 1810
2025
Q2
$1.58M Buy
+13,023
New +$1.47M 0.02% 966
2024
Q4
Sell
-14,771
Closed -$1.7M 1765
2024
Q3
$1.7M Buy
14,771
+12,599
+580% +$1.43M 0.02% 872
2024
Q2
$231K Sell
2,172
-111,940
-98% -$11.2M ﹤0.01% 1422
2024
Q1
$11M Buy
+114,112
New +$11.7M 0.22% 97
2023
Q3
Sell
-31,342
Closed -$3.16M 1713
2023
Q2
$3.16M Buy
31,342
+6,931
+28% +$693K 0.08% 341
2023
Q1
$2.25M Buy
+24,411
New +$2.13M 0.06% 418
2021
Q4
Sell
-23,059
Closed -$1.89M 1529
2021
Q3
$1.89M Buy
+23,059
New +$2.07M 0.15% 184
2021
Q2
Sell
-3,542
Closed -$303K 1377
2021
Q1
$303K Buy
+3,542
New +$318K 0.03% 744
2020
Q2
Sell
-56,748
Closed -$4.68M 1368
2020
Q1
$4.68M Buy
56,748
+19,865
+54% +$1.77M 0.34% 45
2019
Q4
$3.49M Buy
+36,883
New +$3.31M 0.21% 153
2018
Q4
Sell
-31,880
Closed -$2.46M 1232
2018
Q3
$2.46M Buy
+31,880
New +$2.36M 0.19% 170
2018
Q2
Sell
-44,551
Closed -$3.23M 1106
2018
Q1
$3.23M Buy
+44,551
New +$3.39M 0.23% 124

Other funds holding NVS

Trexquant Investment's NVS Position: Q3 2025 in Review

Trexquant Investment sold out of Novartis (NVS) in Q3 2025, closing a stake of 13,023 shares — an estimated $1.58M sold.

Trexquant Investment first reported a position in NVS in Q1 2018 and held it in 12 quarters. The position peaked at $11M in Q1 2024. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Trexquant Investment reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Trexquant Investment sold 13,023 Novartis shares in Q3 2025, an estimated $1.58M.
  • Trexquant Investment first reported a position in Novartis in Q1 2018 and held it in 12 quarters.
  • Trexquant Investment's Novartis position peaked at $11M in Q1 2024.
  • 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Trexquant Investment's 13F filing for Q3 2025, filed 14 Nov 2025.